NDC 68712-027

CNL8

Ciclopirox

CNL8 is a Topical Solution in the Human Prescription Drug category. It is labeled and distributed by Innocutis Holdings Llc. The primary component is Ciclopirox.

Product ID68712-027_b367ac0c-2c88-4c37-809b-da4297a47cc6
NDC68712-027
Product TypeHuman Prescription Drug
Proprietary NameCNL8
Generic NameCiclopirox
Dosage FormSolution
Route of AdministrationTOPICAL
Marketing Start Date2008-10-31
Marketing CategoryANDA / ANDA
Application NumberANDA078270
Labeler NameInnocutis Holdings LLC
Substance NameCICLOPIROX
Active Ingredient Strength2 g/mL
Pharm ClassesDecreased DNA Replication [PE],Decreased Protein Synthesis [PE],Decreased RNA Replication [PE],Protein Synthesis Inhibitors [MoA]
NDC Exclude FlagE
Listing Certified Through2017-12-31

Packaging

NDC 68712-027-01

3 BOTTLE, GLASS in 1 CARTON (68712-027-01) > 5 mL in 1 BOTTLE, GLASS (68712-027-03)
Marketing Start Date2008-10-31
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 68712-027-03 [68712002703]

CNL8 SOLUTION
Marketing CategoryANDA
Application NumberANDA078270
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2011-12-16
Inactivation Date2019-11-13

NDC 68712-027-01 [68712002701]

CNL8 SOLUTION
Marketing CategoryANDA
Application NumberANDA078270
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2008-10-31
Inactivation Date2019-11-13

Drug Details

Active Ingredients

IngredientStrength
CICLOPIROX2.28 g/mL

OpenFDA Data

SPL SET ID:68955ba2-590f-4460-994e-bc481aed3d23
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 309291
  • 847217
  • Pharmacological Class

    • Decreased DNA Replication [PE]
    • Decreased Protein Synthesis [PE]
    • Decreased RNA Replication [PE]
    • Protein Synthesis Inhibitors [MoA]

    NDC Crossover Matching brand name "CNL8" or generic name "Ciclopirox"

    NDCBrand NameGeneric Name
    68712-027CNL8CNL8
    43538-500Ciclodanciclopirox
    43538-501Ciclodanciclopirox
    0168-0314Ciclopiroxciclopirox
    0168-0407CiclopiroxCiclopirox
    0168-0449CiclopiroxCiclopirox
    0168-0522Ciclopiroxciclopirox
    0574-2061CICLOPIROXCICLOPIROX
    0591-2159CiclopiroxCiclopirox
    0713-0317CiclopiroxCICLOPIROX
    21695-475CiclopiroxCiclopirox
    42192-714CiclopiroxCiclopirox
    42192-715CiclopiroxCiclopirox
    45802-141CiclopiroxCiclopirox
    45802-401CiclopiroxCiclopirox
    47781-530CiclopiroxCiclopirox
    50383-419CiclopiroxCiclopirox
    51672-1323CiclopiroxCiclopirox
    51672-1351Ciclopiroxciclopirox
    51672-5302Ciclopiroxciclopirox
    52565-032Ciclopiroxciclopirox
    61360-1351Ciclopiroxciclopirox
    61748-200CICLOPIROXCICLOPIROX
    63629-8620CICLOPIROXCICLOPIROX
    0187-5180Penlacciclopirox

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.